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Purpose: The aim of this study was to investigate the potential association of microRNA-146a (miR-146a) and V-Ets
oncogene homolog 1 (Ets-1) gene polymorphisms with Fuchs Uveitis syndrome (FUS).
Methods: Three single-nucleotide polymorphisms (SNPs), miR-146a/rs2910164, ets-1/rs1128334, and ets-1/rs10893872
were genotyped in 219 Han Chinese patients with FUS and 612 healthy controls using the polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) method. Genotype counts were analyzed by the χ2 test.
Results: No significant difference concerning the genotypic and allelic frequencies of rs2910164, rs1128334, and
rs10893872 polymorphisms could be found between patients with FUS and the normal controls. Analysis according to
gender did not show any influence of sex on the association of miR-146a and Ets-1 with FUS.
Conclusions: Our results suggest that the investigated three SNPs, miR-146a/rs2910164, ets-1/rs1128334, and ets-1/
rs10893872, are not associated with FUS in the Han Chinese population.
Fuchs Uveitis Syndrome (FUS) is a chronic inflammatory
eye  disease,  which  usually  presents  as  unilateral  anterior
uveitis in young adults [1]. It is a speciﬁc uveitis entity usually
manifesting as a mild unilateral anterior uveitis with stellate
medium-sized keratic precipitates (KP) and varying degrees
of iris depigmentation or heterochromia [2-4]. In Chinese
patients it occurs mostly in the third or fourth decades of life
and affects both genders equally. Complicated cataract and
secondary  glaucoma  are  common  in  these  patients  [3].
Although  the  etiology  of  FUS  has  not  yet  been  fully
understood,  several  studies  have  revealed  that  both  viral
infection  and  genetic  risk  factors  may  be  involved  in  its
pathogenesis [5-7]. Makley et al. [8] found that monozygotic
twins both developed Fuchs’ syndrome. Earlier reports have
found that several human leukocyte antigen (HLA) genes,
such as HLA-DRW53 and HLA-CW3 were associated with FUS
[7]. Furthermore, recent studies have shown the association
of  several  non-HLA  genes  including  the  cytotoxic  T  cell
antigen (CTLA) 4 gene, the intercellular adhesion molecule 1
(ICAM-1) gene and the interleukin 23 receptor (IL23R) gene
with this disease [9-11].
As  an  abundant  class  of  highly  conserved  small
noncoding RNAs (18–25 nucleotides long), miRNAs play
critical roles in the regulation of diverse biologic processes,
such  as  development,  infection,  immune  response,
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inflammation  and  tumorigenesis  [12,13].  microRNA-146a
(miR-146a) was reported as a negative regulator of innate
immunity in systemic lupus erythematosus (SLE) patients
[14] and was indicated to be the key regulator during viral
infection  [15-17].  Recent  studies  have  demonstrated  that
single nucleotide polymorphisms (SNPs) located either in the
pre-miRNAs or within miRNA-binding sites are likely to
affect the expression of the miRNA targets and, thus, may
contribute  to  the  susceptibility  to  disease  [18,19].  V-Ets
oncogene homolog 1 (Ets-1) is the first member of the Ets
oncogene family which contributes to tumor development and
progression [20]. It has recently been identified to bind to the
miR-146a promoter region and the Ets-1 level was shown to
markedly affect miR-146a promoter activity in vitro and the
knockdown  of  Ets-1  directly  impaired  the  induction  of
miR-146a [21]. SNPs rs1128334 and rs10893872 located in
the 3′UTR of Ets-1 are on putative miRNA binding sites and
are both associated with SLE in Asian populations [22].
In  view  of  the  important  role  of  miR-146a  in  the
development  of  innate  immunity  and  virus  infection
associated diseases and the potential modulatory effect of
Ets-1 on miR-146a expression, we investigated the association
of rs2910164, rs1128334, and rs10893872 of both genes with
FUS. Unfortunately, we failed to find any association of the
aforementioned three polymorphisms with this disease in a
Han Chinese population.
METHODS
Study  populations:  The  study  groups  comprised  219
unselected, consecutive Han Chinese patients with FUS and
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426612 age-, sex-, ethnic-matched healthy controls who were
recruited from the Uveitis Study Center of the Sun Yat-sen
University (Guangzhou, P.R. China) and the First Affiliated
Hospital of Chongqing Medical University (Chongqing, P.R.
China).  The  diagnosis  of  FUS  was  principally  based  on
clinical manifestations as described earlier [3]. The study was
approved by the Local Ethics Research Committee of The
First Affiliated Hospital of Chongqing Medical University,
and informed consent was obtained from all tested subjects.
The tenets of the Declaration of Helsinki were conducted
during all procedures of this study.
Genomic DNA extraction and genotyping: Genomic DNA
samples  of  patients  with  FUS  and  healthy  controls  were
extracted by using the QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany). Amplification of the target DNA sequence
in  the  miR-146a  and  Ets-1  gene  was  analyzed  by  the
polymerase chain reaction (PCR) using primers presented in
Table 1. Each PCR reaction was conducted in a 10 μl reaction
volume containing 5 μl Premix Taq (Ex Taq Version; TaKaRa
Biotechnology Co. Ltd., Dalian, China), 20 pmol primers, and
0.2 μg of genomic DNA for amplification of the DNA. The
tested  three  SNPs  were  genotyped  by  PCR-restriction
fragment  length  polymorphism  (RFLP)  analysis.  PCR
products  were  digested  with  2  U  of  restriction  enzymes
HSP92II at 37 °C (Promega, Madison, WI) and TSP509I at
65  °C  (Fermentas,  Shenzhen,  China)  overnight.  PCR
fragments were separated on 4% agarose gels. Twenty percent
of the PCR samples were directly sequenced to confirm the
polymerase chain restriction fragment length polymorphism
(PCR-RFLP)  results  (Invitrogen  Biotechnology  Co.,
Guangzhou, China).
Statistical  analysis:  Hardy–Weinberg  equilibrium  (HWE)
was tested in the subjects using the χ2 test. Genotype and allele
frequencies were compared between patients and controls by
the χ2 test using SPSS version 17.0 (SPSS, Inc., Chicago, IL).
Bonferroni  correction  was  used  to  account  for  multiple
testing. A two-tailed pP value <0.05 was considered to be
statistically significant.
RESULTS
Two hundred and nineteen consecutive Han Chinese patients
with  FUS  and  612  healthy  controls  were  enrolled  in  the
present study. The average age of the patients with FUS and
normal controls were 36.4±12.4 years (range: 16 to 62 years)
and 34.6±11.9 years (range: 18 to 57 years) in the present
study, respectively. The age and gender distribution of the
patients with FUS and controls are shown in Table 2.
Three SNPs (rs2910164, rs1128334, and rs10893872)
were successfully genotyped in 219 patients with FUS and
612 healthy controls. The results showed that the distribution
of the genotype and the alleles for each SNP did not deviate
from the Hardy–Weinberg equilibrium (HWE) in FUS and
healthy controls (p>0.05). The distribution of genotypic and
allelic  frequencies  of  the  three  tested  polymorphisms  is
presented in Table 3. There was no statistically significant
difference concerning the genotype and allele of these three
SNPs rs2910164, rs1128334, and rs10893872 between Fuchs’
patients  and  controls.  In  addition,  we  failed  to  find  any
influence  of  sex  on  the  association  of  the  tested  gene
polymorphisms with FUS by stratification analysis according
to gender.
DISCUSSION
The  present  study  did  not  show  an  association  between
miR-146a and Ets-1 polymorphisms and FUS in a Chinese
Han population. A further stratification analysis according to
gender  or  extraocular  findings  also  did  not  show  an
association.
Although the etiology and pathogenesis of FUS are not
fully understood, viral infections and autoimmunity have been
presumed to be involved in its development, as supported by
the  demonstration  of  local  intraocular  antiviral  antibody
TABLE 1. PRIMERS AND RESTRICTION ENZYMES USED IN RFLP ANALYSIS.
SNP Primers Tm (°C) Restriction enzymes
rs2910164 5′-ATGGGTTGTGTCAGTGTCAGACAT-3′ 58 HSP92II
  5′-TGCCTTCTGTCTCCAGTCTTCCAA-3′    
rs1128334 5′-TATTGTGTTTGACTATTTTCCAACAT-3′ 55 HSP92II
  5′-ACTTACATCGCTACATCTCT-3′    
rs10893872 5′-ATCCCAGACCAAACCCAGTA-3′ 60 TSP509I
  5′-TGGGCAGTAACAGGCTCTTT-3′    
               RFLP, restriction fragment length polymorphism.
TABLE 2. AGE AND GENDER DISTRIBUTION IN FUCHS’ PATIENTS AND CONTROLS.
Group Age (y; mean±SD) Age range Male (%) Female (%)
Controls 34.6±11.9 18–57 350 (57.2%) 262 (42.8%)
Fuchs’ patients 36.4±12.4 16–62 117 (53.4%) 102 (46.6%)
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427production, increased expression of interferon-gamma (IFN-
γ) and interleukin 6 in Fuchs’ patients [23-25]. Viral infection
has been shown to be initially recognized by host pattern-
recognition receptors (PRRs), including Toll like receptors
(TLRs), and has been found to be able to up- or down-regulate
the expression of miRNAs in host cells [26]. The role of
miR-146a  in  the  innate  immune  response  was  identified
recently by showing that it could act as a negative feedback
regulator  in  TLR  signaling  by  targeting  IL-1R-associated
kinase  (IRAK)  1  and  TNF  receptor  associated  factor  6
(TRAF6) [27]. Other reports further showed that Epstein-Barr
virus (EBV)-encoded latent membrane protein 1 and pro-
inﬂammatory cytokine IL-1β also induced the expression of
miR-146a [16,28,29], miR-146a was decreased by estrogen
treatment and in turn led to the augmentation of LPS-induced
IFN-γ  in  splenic  lymphocytes  [17].  All  these  studies
collectively indicated that miR-146a is indeed involved in the
much more complex regulatory network of innate immunity
and especially during the viral infection process. In view of
these findings, we chose miR-146a and the transcription factor
Ets-1 as candidates in an association study of FUS in a Chinese
Han population.
Since there are numerous SNPs in a candidate gene and
only a few SNPs may be relevant in the pathogenesis of
disease, it is extremely important to determine how many and
which SNPs should be selected as optimal candidates within
the gene to be tested in an association study. In this study, we
chose three SNPs of miR-146a and Ets-1 mainly based on
earlier studies [22,30,31]. The SNP rs2910164 tested in our
study is the only one reported in the miR-146a precursor and
has been shown to have a quantitative impact on the total
amount  of  miR-146a  [30].  This  SNP  might  reduce  the
efficiency  of  processing  the  pre-miRNA  into  the  mature
miRNA [30]. SNP rs2910164 was shown to be associated with
papillary thyroid carcinoma in a Caucasian population and
with  the  risk  for  hepatocellular  carcinoma  in  a  Chinese
population  [30,31].  Our  inability  to  detect  an  association
between  rs2910164  and  FUS  is  consistent  with  earlier
findings reported in ulcerative colitis or rheumatoid arthritis
in Japanese [32] or Chinese populations [33]. Other two SNP
tested in the present study, rs1128334 and rs10893872, are
located in the 3′ untranslated region (3′UTR) of Ets-1. The
post-transcriptional regulatory effect of miRNA on certain
subsets of mRNAs (mRNAs) is mediated by binding to their
3′UTR  [34].  These  two  SNPs  have  been  reported  to  be
associated with SLE in an Asian population [22]. Our findings
that SNPs rs1128334 and rs10893872 were not associated
with FUS may be explained by the fact that the pathways
leading  to  SLE  and  FUS  are  different  and  that  other
genetically determined risk factors are operational in these
diseases.
As a case-control association study may be influenced by
various factors, the following efforts were used to validate the
results. The healthy controls and patients were strictly age-,
sex-, and ethnically matched to exclude the possible influence
of stratification of the population. Individuals with ocular
inflammation and any autoimmune disease were excluded
from the healthy controls by careful inquiry of history and, if
necessary, by relevant examinations. When the number of
cases is relative small, the ratio of controls to cases can be
raised to improve the ability to ﬁnd important variants [35].
Therefore,  we  have  increased  the  number  of  controls  to
improve the power of the study. To validate the result of
genotyping by PCR-RFLP, 20% of the total samples were
randomly  chosen  and  analyzed  by  direct  sequencing  to
validate the method employed in this study.
TABLE 3. FREQUENCIES OF GENOTYPES AND ALLELES OF MIR-146A AND ETS-1 POLYMORPHISM IN FUCHS’ PATIENTS AND CONTROLS.
SNP Genotype
allele
FUS (n=219) Controls (n=612) χ2 p value pc
value
OR (95% CI)
rs2910164 GG 36 (0.164) 79 (0.129) 1.69 0.21 NS 1.33 (0.87–2.04)
  GC 91 (0.416) 279 (0.456) 1.06 0.34 NS 0.85 (0.62–1.16)
  CC 92 (0.42) 254 (0.415) 0.02 0.94 NS 1.02 (0.75–1.40)
  G 514 (0.431) 437 (0.357) 0.32 0.6 NS 1.07 (0.85–1.34)
  C 678 (0.569) 787 (0.643) 0.32 0.6 NS 0.94 (0.75–1.18)
rs1128334 AA 30 (0.137) 72 (0.118) 0.56 0.47 NS 1.19 (0.75–1.88)
  AG 85 (0.388) 276 (0.451) 2.59 0.11 NS 0.77 (0.56–1.06)
  GG 104 (0.475) 264 (0.431) 1.24 0.27 NS 1.19 (0.88–1.63)
  A 145 (0.331) 420 (0.343) 0.21 0.68 NS 0.95 (0.75–1.19)
  G 293 (0.669) 804 (0.657) 0.21 0.68 NS 1.06 (0.84–1.33)
rs10893872 CC 82 (0.374) 175 (0.286) 5.91 0.017 NS 1.50 (1.08–2.07)
  CT 103 (0.47) 316 (0.516) 1.37 0.27 NS 0.83 (0.61–1.13)
  TT 34 (0.155) 121 (0.198) 1.91 0.19 NS 0.75 (0.49–1.13)
  C 267 (0.61) 666 (0.544) 5.62 0.018 NS 1.31 (1.05–1.63)
  T 171 (0.39) 558 (0.456) 5.62 0.018 NS 0.76 (0.61–0.96)
               Pc, Bonferroni corrected p value. NS=Not significant. OR=odds ratio. 95% CI=95% confidence interval.
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428It  is  worthwhile  to  point  out  that  there  were  several
limitations in the present study. The sample of the patients in
our study seemed to be relatively small and only Han Chinese
cohorts were included. Therefore, the results observed in this
study need to be confirmed using a large sample size and in
other ethnic patients with FUS. In addition, although we failed
to find any association of the investigated three SNPs with
FUS, our study does not rule out the possibility that other
SNPs of Ets-1 are associated with this disease. More studies
are needed to clarify this issue.
In conclusion, our study revealed that the rs2910164,
rs1128334, and rs10893872 SNPs were not associated with
the susceptibility to FUS in this population. Further studies
are necessary to elucidate the association of miR-146a and
Ets-1 polymorphisms with FUS using larger samples and in
multiethnic populations.
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